RecruitingNCT05566249

A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry


Sponsor

Samsung Medical Center

Enrollment

1,000 participants

Start Date

Oct 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating the safety and practicality of using a surgical robotic tool called ArtiSential during colorectal cancer operations. ArtiSential is an articulating laparoscopic instrument — a flexible tool used in minimally invasive surgery — and this study will track whether it is safe and feasible across multiple surgical centers. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with rectal cancer or rectosigmoid junction cancer confirmed by biopsy - It is your first (primary) cancer, without distant spread - You are scheduled for elective (planned, non-emergency) surgery with curative intent - The surgical plan includes a low anterior resection using a double-stapled technique **You may NOT be eligible if...** - You are receiving systemic (full-body) chemotherapy before surgery - Your cancer has spread to distant organs (metastatic) - Surgery is palliative (not aiming for cure) - Your surgery is an emergency - You have Lynch syndrome or familial adenomatous polyposis (FAP)-related cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEArtiSential

Articulating laparoscopic instrument


Locations(1)

Samsung Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05566249


Related Trials